The balance between the potential benefits and harms of opioid use must be considered when managing all patients, but it is less clear how this dilemma impacts our ability to manage urologic postoperative pain, or chronic pain conditions that may be managed by urology providers. This session provides an overview of the opioid crisis and offers insight into its potential to impact the management of urology patients.

Continuing Education Instructions and Disclosure Information

Contact hours available until 10/28/2020.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Planning Committee Disclosures: Heather Schultz, MSN, RN, NP-C - AUA Leadership Position 2018 Program Planner

Speakers Conflict of Interest Disclosure:
Susanne Quallich PhD, ANP-BC, NP-C, CUNP, FAANP
Consultant: Coloplast

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:

The Society of Urologic Nurses and Associates (SUNA) is accredited as a provider of continuing nursing education by the American Nurses’ Credentialing Center’s Commission on Accreditation.

The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
After completing this continuing nursing education activity the learner will be able to discuss factors that created the opioid epidemic and strategies for caring for urology patients that avoid opioid use.